First patient in current dose cohort exhibited no progression of her cancer three months after treatment Multiple patients have survived more than one year, including one beyond two years No dose-limiting toxicities observed to date SAN JOSE, Calif., Oct. 5, 2026 /PRNewswire/ -- Anixa...
Hence then, the article about anixa biosciences announces first case of stable disease for three months in ovarian cancer car t clinical trial was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Anixa Biosciences Announces First Case of Stable Disease for Three Months in Ovarian Cancer CAR-T Clinical Trial )
Also on site :
- Radha Exports partners with Körber for advanced warehouse automation in Singapore
- Linda Evangelista paid $1.4 million in 2001 for a Chelsea penthouse with a 2,500-square-foot roof terrace; 25 years later she sold it for $6.75 million
- In 1974, three artists buried 10 Cadillacs nose-first in an Amarillo, Texas wheat field; the row was moved 2 miles west in 1997 as the city grew